Recent studies have demonstrated that reduced insulin-stimulated muscle glycogen synthesis is the major cause of insulin resistance in patients with non-insulindependent diabetes mellitus (NIDDM). This reduced rate has been assigned to a defect in either glucose transport or hexokinase activity. However it is unknown whether this is a primary or acquired defect in the pathogenesis of NIDDM. To examine this question, we measured the rate of muscle glycogen synthesis and the muscle glucose 6-phosphate (G6P) concentration using 13C and 31P NMR spectroscopy as well as oxidative and nonoxidative glucose metabolism in six lean, normoglycemic offspring of parents with NIDDM and seven age/weight-matched control subjects under hyperglycemic ("11 mM)-hyperinsulinemic (-480 pM) clamp conditions.The offspring of parents with NIDDM had a 50% reduction in total glucose metabolism, primarily due to a decrease in the nonoxidative component. The rate of muscle glycogen synthesis was reduced by 70%o (P < 0.005) and muscle G6P concentration was reduced by 40% (P < 0.003), which suggests impaired muscle glucose transport/hexokinase activity.These changes were similar to those previously observed in subjects with fully developed NIDDM. When the control subjects were studied at similar insulin levels (-440 pM) but euglycemic plasma glucose concentration (-5 mM), both the rate of glycogen synthesis and the G6P concentration were reduced to values similar to the offspring of parents with NIDDM. We conclude that insulin-resistant offspring of parents with NIDDM have reduced nonoxidative glucose metabolism and muscle glycogen synthesis secondary to a defect in muscle glucose transport/hexokinase activity prior to the onset of overt hyperglycemia. The presence of this defect in these subjects suggests that it may be the primary factor in the pathogenesis of NIDDM.Insulin resistance is a primary factor responsible for glucose intolerance in type II, or non-insulin-dependent diabetes mellitus (NIDDM). Studies on both families and populations with a high incidence of NIDDM have found that reduced insulindependent glucose metabolism is frequently found in nondiabetic relatives (1-4) and that it is the best predictor for the later development of the disease (1, 4). Using 13C NMR, we have shown that muscle glycogen synthesis accounts for the majority of insulin-dependent glucose metabolism under hyperglycemic-hyperinsulinemic conditions in healthy control subjects and that reduced muscle glycogen synthesis is the major factor responsible for impaired glucose metabolism in subjects with NIDDM (5). Glucose 6-phosphate (G6P) is an intermediate in the muscle glycogen synthesis pathway, and its concentration depends on the relative activities of the muscle glycogen synthase enzyme and glucose transport into muscle (6-9). In a recent study using 31P NMR, we (6) found that muscle G6P concentration was reduced in subjects with NIDDM, suggesting that reduced activity of muscle glucose transporters or of hexokinase is responsible for the impai...